OLMA · Olema Pharmaceuticals, Inc.
$11.58
-0.18 (-1.53%)
At close · Aug 5
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$985.28M
Shares
87.35M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-01-06 | $150,000,000 | $150,000,000 | 2025-06-30 | — | 10-Q , filed 2025-11-10 |
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
31 filings
31 filers
Visit website
Investor relations